Ftse Mib
34.683,85
-0,43%
DAX
18.557,27
-0,48%
S&P 500
5.350,09
-0,05%
NASDAQ
17.139,37
-0,20%
Bitcoin
69.344,85
-2,01%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Omrix Biopharmaceuticals (MM) (OMRI) Omrix Biopharmaceuticals (MM) (OMRI) Notizie

OMRI

Omrix Biopharmaceuticals (MM) (OMRI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OMRI
DataOraFonteTitoloSimboloCompagnia
30/12/200823:21Edgar (US Regulatory)(25-NSE)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
30/12/200822:59Edgar (US Regulatory)Notice of Termination of a Foreign Private Issuer's Registration of a Class of Securities under Section 12(g) (15F-12G)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
30/12/200821:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
29/12/200815:57MarketwiredBridgewaterEquity.com Free Fundamental Sector & Market Research on BEBE, OMRI, SONS and CALMNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
29/12/200812:27Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
27/12/200816:08PR Newswire (US)Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
19/12/200823:42PR Newswire (US)Johnson & Johnson Extends Tender Offer for Omrix Biopharmaceuticals, Inc.NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
19/12/200822:49Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
18/12/200822:02Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
11/12/200823:40PR Newswire (US)Johnson & Johnson Announces Receipt of Israeli Antitrust Approval for Acquisition of OmrixNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
03/12/200819:45MarketwiredLaw Offices of Brian M. Felgoise, P.C. Announces Class Action Lawsuit on Behalf of Shareholders of Omrix Biopharmaceuticals, IncNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
26/11/200812:01Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
25/11/200823:12Edgar (US Regulatory)Current report filing (8-K)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
25/11/200819:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
25/11/200818:43Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
25/11/200818:38PR Newswire (US)Johnson & Johnson Begins Tender Offer to Acquire OmrixNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
24/11/200823:06Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
24/11/200812:30PR Newswire (US)Johnson & Johnson Announces Definitive Agreement to Acquire OmrixNASDAQ:OMRI
10/11/200817:25Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
06/11/200819:47Business WireOmrix Biopharmaceuticals to Webcast Presentation at Credit Suisse Annual Healthcare ConferenceNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
06/11/200818:16Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
06/11/200813:00Business WireOmrix Biopharmaceuticals Announces Third Quarter 2008 Financial ResultsNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
05/11/200822:52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
04/11/200814:00Business WireOmrix Biopharmaceuticals to Webcast Presentation at Rodman & Renshaw Annual Healthcare ConferenceNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
03/11/200814:00Business WireOmrix Biopharmaceuticals Reschedules its Third Quarter 2008 Financial Results & Conference Call to an Earlier Time on Novembe...NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
24/10/200821:27Business WireOmrix Biopharmaceuticals Announces Patient Enrollment Will Resume In Fibrin Pad U.S. Phase II Clinical Trial In Mild to Moder...NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
21/10/200814:00Business WireOmrix Biopharmaceuticals Announces Third Quarter 2008 Financial Results Date and Conference CallNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
20/10/200813:12Business WireOmrix Biopharmaceuticals Provides Preliminary Third Quarter 2008 Results and Increases 2008 Product Sales GuidanceNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
14/10/200813:00Business WireOmrix Biopharmaceuticals Receives Approval from European Medicines Agency for Evicel Liquid Fibrin Sealant (Human)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
10/10/200823:05Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OMRI

La tua Cronologia

BIT
UCG
Unicredit
BIT
STMMI
ST Microelectronics
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
RACE
Ferrari NV
BIT
BPE
Bper Banca
BIT
TRN
Terna Trasmissione Elett...
BIT
LDO
Leonardo
BIT
SRG
Snam
BIT
IVG
Iveco Group NV
BIT
CPR
Davide Campari
BIT
TEN
Tenaris
BIT
A2A
A2A
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network